JG
ICPT

Jefferies Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jefferies Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,406
Closed -$553K – 2077
2020
Q4 		$553K Buy
22,406
+3,251
+17% +$108K ﹤0.01% 1099
2020
Q3 		$794K Buy
19,155
+14,833
+343% +$682K 0.01% 862
2020
Q2 		$207 Buy
4,322
+1,019
+31% +$78.7K ﹤0.01% 1069
2020
Q1 		$208K Sell
3,303
-25,955
-89% -$2.33M ﹤0.01% 1669
2019
Q4 		$3.63M Buy
29,258
+28,708
+5,220% +$2.57M 0.03% 693
2019
Q3 		$36K Sell
550
-30,070
-98% -$2.02M ﹤0.01% 2602
2019
Q2 		$2.44M Buy
30,620
+29,211
+2,073% +$2.61M 0.02% 821
2019
Q1 		$158K Sell
1,409
-1,286
-48% -$141K ﹤0.01% 2015
2018
Q4 		$272K Buy
+2,695
New +$279K ﹤0.01% 1693
2018
Q1 		– Sell
-66,313
Closed -$3.87M – 2827
2017
Q4 		$3.87M Sell
66,313
-192,446
-74% -$12.1M 0.02% 663
2017
Q3 		$15M Buy
258,759
+256,831
+13,321% +$27.7M 0.1% 180
2017
Q2 		$233K Buy
+1,928
New +$223K ﹤0.01% 1992
2017
Q1 		– Sell
-543
Closed -$59K – 2724
2016
Q4 		$59K Sell
543
-12,755
-96% -$1.52M ﹤0.01% 2074
2016
Q3 		$2.19M Buy
+13,298
New +$2.1M 0.01% 884
2016
Q2 		– Sell
-2,523
Closed -$324K – 2517
2016
Q1 		$324K Sell
2,523
-69
-3% -$8.15K ﹤0.01% 1639
2015
Q4 		$387K Buy
2,592
+1,009
+64% +$171K ﹤0.01% 1662
2015
Q3 		$263K Buy
1,583
+1,579
+39,475% +$347K ﹤0.01% 1826
2015
Q2 		$1K Buy
+4
New +$1.06K ﹤0.01% 3228
2014
Q4 		– Sell
-7,960
Closed -$1.47M – 2431
2014
Q3 		$1.88M Buy
7,960
+6,015
+309% +$1.53M 0.01% 754
2014
Q2 		$461K Buy
+1,945
New +$513K ﹤0.01% 1275

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jefferies Group's ICPT Position: Q1 2021 in Review

Jefferies Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 22,406 shares — an estimated $553K sold.

Jefferies Group first reported a position in ICPT in Q2 2014 and held it in 20 quarters. The position peaked at $15M in Q3 2017. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

  • Jefferies Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 22,406 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $553K.
  • Jefferies Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
  • Jefferies Group's Intercept Pharmaceuticals, Inc. position peaked at $15M in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.